Navigation Links
New resource opens the door for enzyme research
Date:2/27/2012

The European Molecular Biology Laboratory's European Bioinformatics Institute has launched the Enzyme Portal, a freely available resource for people who are interested in the biology of enzymes and proteins with enzymatic activity.

Enzymes catalyse the myriad reactions that take place in living organisms, allowing chemical changes to occur that would otherwise need conditions that are incompatible with life. Until now, information about enzymes was scattered throughout many different resources. This meant that you had to know exactly what you were looking for, which could be a real barrier to discovery.

The Enzyme Portal mines and displays data about proteins with enzymatic activity from public repositories via a single search, and includes biochemical reactions, biological pathways, small molecule chemistry, disease information, 3D protein structures and relevant scientific literature. It summarises information in the UniProt knowledge base; the Protein Data Bank in Europe; Rhea, a database of enzyme-catalysed reactions; Reactome, a database of biochemical pathways; IntEnz, a resource with enzyme nomenclature information; ChEBI and ChEMBL, which contain information about small-molecule chemistry and bioactivity; and CoFactor and MACIE for highly detailed, curated information about cofactors and reaction mechanisms.

The Enzyme Portal covers a large number of species, including the key organisms used in biological research, and makes it simple to compare the characteristics of equivalent enzyme activities in different organisms.

"The Enzyme Portal will serve researchers interested in the native metabolism of organisms as well as those working in drug discovery or chemical biology," explained Dr Christoph Steinbeck, Head of Cheminformatics and Metabolism at EMBL-EBI. "The resource seamlessly bridges the various enzyme-related aspects of these areas, all the way from the small molecules which may occur naturally in the organism of study or be introduced to the 3D structure of the enzymes affected and the genomic information coding for those."

The design of the Enzyme Portal was based entirely on user demand and feedback. "We didn't come in with preconceived ideas of what it should be; it was designed by users, for users," said Cheminformatics Coordinator Paula de Matos. "We had enough data, but it was distributed over 10 different resources. Now, we have a central place where they can access and explore all of it including information about disease."

"The Enzyme Portal takes the researcher's perspective," added User Experience Analyst Jenny Cham. "We leveraged user-testing feedback to create it, making it the first EMBL-EBI resource to have a fully user-centred design from scratch. This approach was not only cost-effective; it made decision making and communication much easier particularly in terms of design and technology choices."


'/>"/>

Contact: Mary Todd Bergman
contactpress@ebi.ac.uk
44-122-349-4665
European Molecular Biology Laboratory - European Bioinformatics Institute
Source:Eurekalert  

Related biology news :

1. Engineers improve allocation of limited health care resources in resource-poor nations
2. Wild west approach to claiming the oceans genetic resources must end: UBC media release
3. North Carolina-based genetic resources fuel big scientific progress
4. New mouse collaborative cross resource promises new cures and treatments for diseases
5. Open access: Comprehensive occupational health and safety resource now available online
6. Eyeing resources, India, China, Brazil, Japan, other countries want a voice on Arctic Council
7. Global resource for clinical microbiologists and immunologists debuts
8. Mite-y genomic resources for bioenergy crop protection
9. Effects of climate change to further degrade fisheries resources: UBC researchers
10. NOAA releases status on Florida Keys National Marine Sanctuary marine resources
11. 3-D microscope opens eyes to prehistoric oceans and present-day resources
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New resource opens the door for enzyme research
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, ... Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ... to deliver therapeutic levels of olanzapine for a period of 3 months., “We are ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/23/2017)... 23, 2017 ... per share data, unaudited)Three Months Ended December 31,Twelve Months ... $         ...   89026%Aldurazyme Net Product Revenue ... Net Product Revenue  756025%297303(2)%Vimizim Net ...
Breaking Biology Technology: